For NSCLC, signatures of CT, fusion characteristics of ceCT, and PET forecasted EGFR mutations and anaplastic lymphoma kinase rearrangements, EGFR and Kirsten rat sarcoma virus positivity (48, 49, 66), respectively. The gene discussed is ALK; the disease is non-small cell lung carcinoma.